1. Medtech Insight
  2. >>Archive

Indian Government Appoints Panel To Restrict Import Of Refurbished Radiology Devices

 
• By Vibha Sharma

The Indian government has issued orders to appoint an inter-ministerial committee to restrict the import of refurbished radiology devices and to examine whether to stop such imports, the approval requirements that are in place for such products, concerns around patient safety and the barriers faced by the domestic industry1.

The Indian government has issued orders to appoint an inter-ministerial committee to restrict the import of refurbished radiology devices and to examine whether to stop such imports, the approval requirements that are in place for such products, concerns around patient safety and the barriers faced by the domestic industry1.

While the government has not provided any information on when and how the restriction on imported refurbished radiology devices would come into play, a key importer of such devices in...

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By Ryan Nelson

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By Ryan Nelson

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By Marion Webb

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 
• By Natasha Barrow

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight